Science Translational Medicine -- Purchase Short-Term Access

Purchase Short-Term Access

Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors
Gholamin et al. Sci Transl Med 2017 9 (381), p. eaaf2968



 required


Your receipt will be sent to this email address. If you have previously purchased access to content on this site, please enter the same email address so we can detect any duplicate purchases.

You may view, download, and/or print the article for your personal scholarly, research, and educational use. You may not (i) distribute a copy (electronic or otherwise) of the article without the written permission of AAAS, (ii) post the article on an electronic bulletin board or web site, or (iii) charge for a copy (electronic or otherwise) of the article.